Keloids: Prevention and Management - 20/08/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Résumé |
Keloids result from an abnormal wound-healing process in which the normal regulatory pathways during tissue regeneration and scar remodeling are disrupted. While the pathogenesis of keloids continues to be investigated, numerous treatment options exist. Although prevention of keloid formation is the best management, early recognition of keloid formation is integral in treatment and prevention of recurrence. Surgical resection with adjuvant silicone gel sheeting or triamcinolone injection is common, but can still result in recurrence. New treatments include chemotherapeutics such as 5-fluorouracil, bleomycin, and mitomycin C. Although further clinical investigation is required for newer treatments, initial results are promising.
Le texte complet de cet article est disponible en PDF.Keywords : Keloid, Scar management, Hypertrophic scars, Wound healing, Keloid pathophysiology
Plan
Disclosure Statement: The authors have no financial obligations to disclose. |
Vol 19 - N° 3
P. 505-515 - août 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?